Consolidated Statements of Cash Flow - USD ($)	12 Months Ended
	Mar. 31, 2021	Mar. 31, 2020
Cash flows from operating activities:
Net Loss	$ (7,812,294)	$ (14,556,680)
Adjustments to reconcile Net Loss to Net Cash used in operations:
Depreciation and amortization	4,876,756	4,455,962
Debt discount amortization	446,466	115,533
Employee stock awards	1,450,359	901,526
Stock grants	278,585	534,929
Stock for services	1,707,500	352,300
Contingent consideration payable fair value	(119,731)	(190,377)
Interest on convertible promissory notes	163,351
Allowance for doubtful accounts	86,292	(67,117)
Paycheck protection program note forgiveness	(1,051,985)
Loss on disposal of assets	25,400
Stock issued in lieu of cash payments	48,000
Reduction in right of use asset	443,739	381,140
Loss on Jagemann Munition Components	1,000,000
Stock and warrants for note conversion	1,315,494
Changes in Current Assets and Liabilities
Accounts receivable	(6,075,373)	(1,679,887)
Due to (from) related parties	150	3,758
Inventories	(11,458,845)	364,524
Prepaid expenses	(1,331,710)	148,982
Deposits	(1,616,858)	(178,287)
Accounts payable	1,810,417	3,277,010
Accrued liabilities	1,843,166	1,106,411
Operating lease liability	(444,439)	(329,162)
Net cash used in operating activities	(14,415,560)	(5,359,435)
Cash flows from investing activities
Purchase of equipment	(7,437,265)	(462,385)
Net cash used in investing activities	(7,437,265)	(462,385)
Cash flow from financing activities
Proceeds from inventory facility	1,091,098
Proceeds from factoring liability, net	40,309,292	9,747,281
Payments on factoring liability	(40,473,083)	(7,741,302)
Proceeds from paycheck protection program notes	1,051,985
Proceeds from note payable related party issued	3,500,000	819,731
Payments on note payable - related party	(8,783,410)	(1,885,000)
Payments on insurance premium note payment	(514,746)	(466,421)
Proceeds from note payable	4,000,000
Proceeds from convertible promissory notes	1,959,000	2,171,000
Sale of common stock	138,612,619	2,465,540
Common stock issued for exercised warrants	13,952,336
Common stock issuance costs	(13,895,069)	(285,981)
Payments on common stock repurchase and cancellation	(1,500,000)
Contingent consideration payment		(300,000)
Net cash provided by financing activities	139,310,022	4,524,848
Net increase/(decrease) in cash	117,457,197	(1,296,972)
Cash, beginning of period	884,274	2,181,246
Cash, end of period	118,341,471	884,274
Supplemental cash flow disclosures
Cash paid during the period for: Interest	1,186,302	531,274
Cash paid during the period for: Income taxes
Non-cash investing and financing activities:
Accounts payable	(2,635,797)
Note payable related party	2,635,797
Right of use assets - operating leases	(897,845)	(3,771,873)
Operating lease liability	897,845	3,812,886
Rent Expense		(41,013)
Insurance premium note payment	226,539	565,548
Prepaid expenses	(226,539)	(565,548)
Convertible promissory note	(4,459,000)
Note issuance costs	(208,855)
Convertible promissory note conversion	4,667,855	318,226
Convertible promissory note		(318,226)
Note payable related party conversion	2,100,000
Note payable related party	(2,100,000)	(2,596,200)
Accounts receivable		(31,924)
Deposits		(9,250)
Equipment		1,871,306
Other intangible assets		766,068
Stock subscription receivable	(664,975)
Common stock	310
Additional paid-in capital	664,665
Total non-cash investing and financing activities